Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Krahl, A."'
Autor:
Dietger Niederwieser, Rainer Krahl, Uwe G. Liebert, Elvira Edel, Claudia Wickenhauser, Marianne Hehme, Haifa Kathrin Al-Ali, Sabine Leiblein, Mark Westerman, Nadja Jaekel
Publikováno v:
Blood. 116:1307-1307
Abstract 1307 Iron homeostasis is controlled through a coordinated activity of multiple proteins through different signaling pathways with hepcidin being the central regulatory hormone. Iron overload in recipients of allogeneic hematopoietic cell tra
Autor:
Uwe G. Liebert, Haifa Kathrin Al-Ali, Rainer Krahl, Marianne Hehme, Mark Westerman, Sabine Leiblein, Ann-Kathrin Eisfeld, Dietger Niederwieser
Publikováno v:
Blood. 114:4047-4047
Abstract 4047 Poster Board III-982 Hepcidin (hep), a 25-amino-acid peptide, is the central regulator of iron homeostasis. Its transcription is upregulated by inflammatory cytokines and iron and is downregulated by iron deficiency, ineffective erythro
Autor:
Christa Doering, Medical Student, Rainer Krahl, Elvira Edel, Sabine Schroeder, Ann-Kathrin Eisfeld, Haifa Kathrin Al-Ali, Dietger Niederwieser, Ralph Burkhardt
Publikováno v:
Blood. 106:3717-3717
Introduction: Iron metabolism plays an important role in hematopoiesis and immune response. In the present project, body iron stores and factors affecting iron storage such as HFE genotype and the number of blood transfusions were evaluated in patien
Autor:
Ralph Burkhardt, Dietger Niederwieser, Christa Doehring, Elvira Edel, Sabine Schroeder, Andrea Junghans, Ann-Kathrin Eisfeld, Uwe G. Liebert, Haifa Kathrin Al-Ali, Daniel Teupser, Rainer Krahl
Publikováno v:
Blood. 106:1812-1812
Risk factors for morbidity and treatment related mortality (TRM) following HCT have been well defined in retrospective analysis and prospective validations. These include disease-, recipient- and donor-specific characteristics, but not treatment rela
Autor:
Ralph Burkhardt, Andrea Junghans, Daniel Teupser, Ann-Kathrin Eisfeld, Dietger Niederwieser, Joachim Thiery, Sabine Schroeder, Haifa Kathrin Al-Ali, Rainer Krahl, Elvira Edel, Christa Doehring
Publikováno v:
Blood. 104:3684-3684
Introduction: A substantial proportion of European populations (10–40%) are heterozygous carriers (het) and 0.1–0.3% homozygos (homo) for the hemochromatosis gene (HFE). Patients (pts) with hematologic malignancies often receive multiple blood tr
Autor:
Haifa Kathrin Al-Ali, Mathias Orth, Sandra Otto, Silke Perlowski, Michael W. Deininger, Dietger Niederwieser, Rainer Krahl
Publikováno v:
Blood. 104:2933-2933
Introduction : Myalgias and muscle cramps occur in 11% and 33% of patients (pts) on imatinib, but are usually not dose-limiting. Rhabdomyolysis has been reported once. We analysed serial creatine kinase (CK) levels and their correlation with clinical